Company intelligence / Profile preview

Rigaku Holdings

Akishima, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Rigaku is a leading global provider of analytical and imaging instruments, with a significant focus on X-ray and molecular imaging systems used in life sciences, biotechnology, and pharmaceutical research. They offer devices for atomic to organism-scale analyses, including advanced solutions for protein crystallography and preclinical molecular imaging.

Modalities: DeviceImaging system
Industry: Medical Imaging

Partnerships

Academic institutions and large life science/biopharma companies as customers; no disclosed formal biopharma R&D alliances.

Beyond the preview

Go deeper on Rigaku Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rigaku Holdings.

Explore the full profile